The role of protein SUMOylation in rheumatoid arthritis
Autor
Dehnavi S.
Sadeghi M.
Johnston T.P.
Barreto G.
Shohan M.
Sahebkar A.
Resumen
Small ubiquitin-like modifier (SUMO) proteins, as a subgroup of post-translational modifiers, act to change the function of proteins. Through their interactions with different targets, immune pathways, and the responses they elicit, can be affected by these SUMO conjugations. Thus, both a change to protein function and involvement in immune pathways has the potential to promote an efficient immune response to either a pathogenic challenge, or the development of an imbalance that could lead to an autoimmune-based disease. Also, a variety of changes such as mutations and polymorphisms can interfere with common functions of these modifications and move an effective immune response in the direction of an autoimmune disease. The present review discusses the general characteristics of SUMO proteins and focuses on their involvement in rheumatoid arthritis as an autoimmune disease. © 2019 Elsevier Ltd
Colecciones
Ítems relacionados
Mostrando ítems relacionados por Título, autor o materia.
-
Short Survey
Genetics of rheumatoid arthritis: A new boost is needed in Latin American populations (2020)
Castro-Santos P.; Díaz-Peña R. (Elsevier Editora Ltda, 2016) -
Review
HNE-modified proteins in Down syndrome: Involvement in development of Alzheimer disease neuropathology (2020)
Barone E.; Head E.; Butterfield D.A.; Perluigi M. (Elsevier Inc., 2017) -
Review
Genomics, proteomics and metabolomics: Their emerging roles in the discovery and validation of rheumatoid arthritis biomarkers (2020)
Castro-Santos P.; Laborde C.M.; Díaz-Peña R. (Clinical and Experimental Rheumatology S.A.S., 2015)